Wireless energy behaviour monitoring (Wi-be) for office buildings

This paper presents a study on reduction of energy consumption in buildings through behaviour change informed by wireless monitoring systems for energy, environmental conditions and people positions. A key part to the Wi-Be system is the ability to accurately attribute energy usage behaviour to individuals, so they can be targeted with specific feedback tailored to their preferences. The use of wireless technologies for indoor positioning was investigated to ascertain the difficulties in deployment and potential benefits. The research to date has demonstrated the effectiveness of highly disaggregated personal-level data for developing insights into people’s energy behaviour and identifying significant energy saving opportunities (up to 77% in specific areas). Behavioural research addressed social issues such as privacy, which could affect the deployment of the system. Radio-frequency research into less intrusive technologies indicates that received-signal-strength-indicator-based systems should be able to detect the presence of a human body, though further work would be needed in both social and engineering areas.

Josephine: desire, ambition, Napoleon

Biography of Josephine Bonaparte. The incredible rise and unbelievable fall of Josephine, a mistress, courtesan and Revolutionary heroine whose energy and ambition has often been overshadowed by Napoleon’s military might. Historian Kate Williams, author of Becoming Queen, tells Josephine’s searing story of sexual obsession, politics and surviving as a woman in a man’s world. Abandoned in Paris by her aristocratic husband, Josephine's future did not look promising. But while her friends and contemporaries were sent to the guillotine during the Terror that followed the Revolution, she survived prison and emerged as the doyenne of a wildly debauched party scene, surprising everybody when she encouraged the advances of a short, marginalised Corsican soldier, six years her junior. Josephine, the fabulous hostess and skilled diplomat, was the perfect consort to the ambitious but obnoxious Napoleon. With her by his side, he became the greatest man in Europe, the Supreme Emperor; and she amassed a jewellery box with more diamonds than Marie Antoinette’s. But as his fame grew, Napoleon became increasingly obsessed with his need for an heir and irritated with Josephine’s extravagant spending. The woman who had enchanted France became desperate and jealous. Until, a divorcee aged forty-seven, she was forced to watch from the sidelines as Napoleon and his young bride produced a child.

The storms of war

The Storms of War, is the first in a trilogy about the de Witt family. The first explores their lives from 1914-1918, as the youngest girl, Celia, sees her perfect world crumble and change. Inspired to write about the wars since Kate visited the trenches in France when she was ten on a school trip. Kate was fascinated by how small they were - and how men could ever live in such places. She really wanted to go into the lives of Germans - the Victorians couldn't get enough of them. Then - almost overnight - they were the enemy and people saw German spies everywhere and the newspapers demanded that all Germans in the country be imprisoned. At the beginning of the book, Rudolf and Verena have four children - and their lives will never be the same again.

The edge of the fall

Edge of the Fall, is about the DeWitt family in the 1920s as they try to make sense of their lives in the aftermath of the war. It's the Flapper Age - and everything is in flux. A sequel to The Storms of War.

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort

Background Major Depressive Disorder (MDD) is among the most prevalent and disabling medical conditions worldwide. Identification of clinical and biological markers (“biomarkers”) of treatment response could personalize clinical decisions and lead to better outcomes. This paper describes the aims, design, and methods of a discovery study of biomarkers in antidepressant treatment response, conducted by the Canadian Biomarker Integration Network in Depression (CAN-BIND). The CAN-BIND research program investigates and identifies biomarkers that help to predict outcomes in patients with MDD treated with antidepressant medication. The primary objective of this initial study (known as CAN-BIND-1) is to identify individual and integrated neuroimaging, electrophysiological, molecular, and clinical predictors of response to sequential antidepressant monotherapy and adjunctive therapy in MDD. Methods CAN-BIND-1 is a multisite initiative involving 6 academic health centres working collaboratively with other universities and research centres. In the 16-week protocol, patients with MDD are treated with a first-line antidepressant (escitalopram 10–20 mg/d) that, if clinically warranted after eight weeks, is augmented with an evidence-based, add-on medication (aripiprazole 2–10 mg/d). Comprehensive datasets are obtained using clinical rating scales; behavioural, dimensional, and functioning/quality of life measures; neurocognitive testing; genomic, genetic, and proteomic profiling from blood samples; combined structural and functional magnetic resonance imaging; and electroencephalography. De-identified data from all sites are aggregated within a secure neuroinformatics platform for data integration, management, storage, and analyses. Statistical analyses will include multivariate and machine-learning techniques to identify predictors, moderators, and mediators of treatment response. Discussion From June 2013 to February 2015, a cohort of 134 participants (85 outpatients with MDD and 49 healthy participants) has been evaluated at baseline. The clinical characteristics of this cohort are similar to other studies of MDD. Recruitment at all sites is ongoing to a target sample of 290 participants. CAN-BIND will identify biomarkers of treatment response in MDD through extensive clinical, molecular, and imaging assessments, in order to improve treatment practice and clinical outcomes. It will also create an innovative, robust platform and database for future research.